BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update
Newsfile Corp•11/08/2026•06:30 ET
0
Whiz Insights
* Secured first ever CDMO Manufacturing Agreement supporting planned 20-ton commercial production program over two years for rare botanical fragrance, that BioHarvest expects to drive profitable growth trajectory for CDMO business * Reports $8.8 million in Q2 revenue, up 3.8% from Q2 2025
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 11, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced results from the second quarter and six months of 2026.
Get started
Create a free account to read the full story.